Dibucain en es it fr

Dibucain Brand names, Dibucain Analogs

Dibucain Brand Names Mixture

  • No information avaliable

Dibucain Chemical_Formula

C21H27NO

Dibucain RX_link

No information avaliable

Dibucain fda sheet

Dibucain FDA

Dibucain msds (material safety sheet)

Dibucain MSDS

Dibucain Synthesis Reference

No information avaliable

Dibucain Molecular Weight

309.445 g/mol

Dibucain Melting Point

No information avaliable

Dibucain H2O Solubility

No information avaliable

Dibucain State

Solid

Dibucain LogP

4.86

Dibucain Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Dibucain Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Dibucain Pharmacology

No information avaliable

Dibucain Absorption

Well absorbed from gastrointestinal tract following oral administration.

Dibucain side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Dibucain Patient Information

No information avaliable

Dibucain Organisms Affected

Humans and other mammals